Cemdisiran, a small interfering RNA drug that Regeneron Pharmaceuticals licensed from Alnylam Pharmaceuticals, met the goals of its pivotal test in generalized myasthenia gravis. The rare neuromuscular disease has several new therapies, but analysts see cemdisiran as having advantages over one particular class of drugs. The post Regeneron’s RNA Med for Muscle Disease Meets Trial…
Dreem Health introduced partnerships with Moona Health, DrLullaby and Daybreak. The partnerships aim to improve care for sleep conditions like insomnia and sleep apnea. The post Dreem Health Launches 3 Partnerships to Address Sleep Disorders appeared first on MedCity News.
LB Pharmaceuticals’ planned IPO will fund late-stage clinical development of LB-102, a once-daily pill designed to improve on the old Sanofi schizophrenia drug Solian. The IPO filing follow a corporate restructuring in May that cut the jobs of LB’s chief financial and scientific officers to streamline operations and extend its cash runway. The post With…
Health care in the United States is confusing for patients and consumers. Price transparency is a step in the right direction — transformative change can happen by combining cost, quality, appropriateness and efficiency measures. The post Healthcare Price Transparency is Not Enough appeared first on MedCity News.
[Sponsored] Mobile IV therapy brings hydration and wellness straight to your door. Compare top providers, including Mountain Rocky IV Medics, and find the right fit for your health needs. The post On-Demand Relief: What IV Therapy Company Offers the Fastest Service? appeared first on MedCity News.
As operating environments become more complex, every element and system must be reliable, safe, and compliant with the web of regulations. Testing is the antidote to address these issues, however, this presents a significant testing burden. Here are some key challenges. The post Evaluating the Complexities of the Digital Operating Room appeared first on MedCity News.
In July 2025, the Trump administration announced a new effort (“Making Health Tech Great Again”) towards health data interchange.. This brief describes the new, voluntary Trump administration interoperability initiative, provides an overview of key health information technology laws and regulations, and highlights some of the challenges and limitations of these efforts.
This analysis examines the recent growth of Medicare Advantage as a share of hospital inpatient days. Medicare Advantage rose from 13% to 25% of all inpatient days from 2015 to 2023, although there was wide variation among hospitals.
For the most part, Keyanna Jones and her husband thought they knew what to expect when their daughter Chloë had eye surgery last fall. Even Chloë, who was in kindergarten, had a good understanding of how things would go that day. Before the procedure, a hospital worker gave her a coloring book that explained the…
The Trump administration’s cuts to Centers for Disease Control and Prevention funding for state and local health departments had vastly uneven effects depending on the political leanings of a state, according to a KFF Health News analysis. Democratic-led states and select blue-leaning cities fought back in court and saw money for public health efforts restored…